MAPT and Alzheimer disease: Accordingly, an altered ratio of Tau isomers has been linked with neurofibrillary pathology and neurodegeneration [151], and glycation of these variants in AD promotes phosphorylation events that disturb the normal isoform balance in the brain [148].